Joint modeling of overall survival (OS) and tumor size for patient-level predictions of survival in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Onishchenko, Dmitry [1 ]
Dunyak, James [2 ]
Masson, Eric [2 ]
Helmlinger, Gabriel [2 ]
Peskov, Kirill [1 ]
Tomkinson, Helen [4 ]
Stanski, Donald [3 ]
Al-Huniti, Nidal [2 ]
机构：
[1] M&S Decis LLC, Moscow, Russia
[2] AstraZeneca, IMED Biotech Unit, Quantitat Clin Pharmacol, Waltham, MA USA
[3] AstraZeneca, IMED Biotech Unit, Quantitat Clin Pharmacol, Gaithersburg, MD USA
[4] AstraZeneca, IMED Biotech Unit, Quantitat Clin Pharmacol, Cambridge, England
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-091
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] The Plasma Concentration of Epidermal Growth Factor Receptor (EGFR) and Overall Survival (OS) in Non-Small Cell Lung Cancer (NSCLC) Patients
    Ye, P.
    Zhao, J.
    Maihle, N.
    Wang, S. L.
    Jin, J. Y.
    Kong, F. M. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E445 - E445
  • [22] Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival
    Wang, Zhaoxi
    Choi, Sojung
    Lee, Jinseon
    Huang, Yen-Tsung
    Chen, Feng
    Zhao, Yang
    Lin, Xihong
    Neuberg, Donna
    Kim, Jhingook
    Christiani, David C.
    [J]. CANCER INFORMATICS, 2015, 14 : 1 - 9
  • [23] Relationship between age treatment and overall survival in patients with non-small cell lung cancer (NSCLC)
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Georgopoulou, A.
    [J]. LUNG CANCER, 2007, 55 : S10 - S10
  • [24] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [25] Long Overall Survival with Atezolizumab in non-small cell Lung Cancer
    Numberger, Markus
    [J]. PNEUMOLOGIE, 2021, 75 (04):
  • [26] Long Overall Survival with Atezolizumab in non-small cell Lung Cancer
    不详
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (01)
  • [27] Tumor regression as a continuous variable and survival in advanced non-small cell lung cancer (NSCLC).
    Stewart, David J.
    Lu, Charles
    Saintigny, Pierre
    Goss, Glenwood D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Joint Modeling of Stress and Survival in Patients with Advanced Non-Small Cell Lung Cancer
    Arrato, N.
    Brock, G.
    Mcelroy, J.
    Andersen, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S119 - S120
  • [29] QUANTITATIVE MODELING AND SURVIVAL ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
    Lee, T.
    Cao, Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S29 - S29
  • [30] ASSOCIATION BETWEEN TUMOR HETEROGENEITY AND OVERALL SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Song, Jiangdian
    Dong, Di
    Huang, Yanqi
    Liu, Zaiyi
    Tian, Jie
    [J]. 2016 IEEE 13TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2016, : 1249 - 1252
12345